Arctostaphylos Uva-Ursi Leaf.
Research-backed herb with potential health benefits. An active ingredient, arbutin, converts to an antiseptic right inside your bladder.
Reviewed March 2026
- Category
- Herb
What Arctostaphylos Uva-Ursi Leaf is, and what it does.
- Does it work
- Maybe. For that 'uh-oh' moment when you feel a UTI coming on. It's a decent first step. But if you're in real pain, skip this and get antibiotics.
- How much to take
- Depends on the extract's arbutin content. Typically 250-500mg of a standardized extract, 2-3 times a day. Do not exceed 7 days of continuous use.
- Time to feel it
- It's used in short courses. Monograph literature caps continuous use at a few days at a time, so any change in urinary comfort is judged inside that window.
- The first dose
- You might start to notice a slight reduction in urinary urgency or burning. It needs a day or two to really get working.
- With regular use
- Don't use it long term. That's the whole point. This is a 1-week intervention, not a daily supplement.
- How well tolerated
- Strictly for short-term use. The active compound breaks down into something that can be toxic with prolonged exposure. Not for kids, pregnant women, or anyone with kidney problems.
- How it feels
- You don't feel a buzz. You're just hoping to feel less UTI discomfort. It's a functional tool, not an experience.
- The overlooked benefit
- Dried leaf runs fifteen to twenty percent tannins, which bind minerals in the gut, so keep an iron or zinc serving a couple of hours away from it.
400 to 800mg a day is where Arctostaphylos Uva-Ursi Leaf works.
Source: EMA herbal monograph on Uva-ursi; Larsson et al. J Clin Pract 1993
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Arctostaphylos Uva-Ursi Leaf is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Urinary tract comfort over a short courseRandomised trial
- Arbutin conversion to hydroquinone conjugates cleared in urineNarrative review
- Urinary pH influencing release of the free aglyconeNarrative review
- Tannin content binding dietary and supplemental mineralsNarrative review
- Short-course use limits set in monograph literatureNarrative review
Questions people ask about Arctostaphylos Uva-Ursi Leaf.
- Is this a substitute for antibiotics?
- No. It's for mild, early symptoms. If you have a fever, back pain, or feel really sick, see a doctor immediately.
- Why can't I take it for more than a week?
- It produces a compound called hydroquinone in your body. Fine for a few days, but toxic to your liver with long-term use.
- Does it work for all UTIs?
- It's best for uncomplicated bladder infections. It's not effective for more serious kidney infections.
- Do I need to change my diet while taking it?
- Some old advice says to make your urine more alkaline (eat veggies, avoid acidic foods) to help it work better. The evidence is mixed, but it won't hurt.
- Any side effects I should watch for?
- Mostly nausea or an upset stomach. If that happens, stop taking it. It can also turn urine a greenish-brown color, which is harmless.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Arbutin is carried to the urinary tract and releases its hydroquinone aglycone in favour of alkaline conditions, so raising urinary pH raises the active fraction. Traditional monographs pair bearberry with an alkalinising agent for exactly this reason.
Citrate is oxidised to bicarbonate and raises urinary pH, the condition under which arbutin's aglycone release is favoured. It is the usual alkalinising partner where a sodium load is unwanted.
Bicarbonate delivered as the potassium salt shifts urinary pH upward without adding sodium. That shift is the one arbutin's release chemistry depends on.
High-dose ascorbate lowers urinary pH, the opposite of the condition that favours arbutin's aglycone release. Combining the two works against the bearberry mechanism rather than with it.
Cranberry's quinic and hippuric acid load pushes urinary pH down, the wrong direction for arbutin. The two urinary botanicals are often combined in commerce despite pulling against each other on pH.
D-mannose is excreted largely unchanged and occupies bacterial type 1 fimbrial adhesins in the urine, a mechanism unrelated to arbutin chemistry and unaffected by pH. The two are long-standing formulation partners.
Bearberry leaf is high in galloyl tannins, which bind non-heme iron in the gut lumen and form complexes that are poorly taken up. Separate the two by a couple of hours.
Uva-ursi leaf is heavily tannic, and tannins bind divalent metal cations into poorly absorbed complexes in the gut. Taking a zinc supplement in the same window means part of the mineral dose is bound rather than absorbed. Separating the two by a couple of hours is the ordinary way around it.
The same tannin chemistry that binds iron and zinc binds calcium. The effect is on what stays soluble and absorbable in the gut, not on calcium handling once absorbed. Spacing doses is the practical response.
Uva-ursi already carries a large tannin fraction, roughly a fifth of the dried leaf by common description. Adding a further tannin source stacks the same astringent and mineral-binding chemistry rather than adding anything new. The additive direction is worth flagging for gastric tolerance as well as for minerals.
Catechins and leaf tannins bind non-heme iron and other divalent minerals by the same galloyl-group chemistry. Both are also handled by glucuronidation and sulphation, the routes that also conjugate arbutin's hydroquinone metabolites. Stacking them raises the combined load on both systems.
Dandelion and uva-ursi appear together in traditional urinary-support formulas, dandelion contributing its diuretic reputation and uva-ursi its arbutin. The pairing is convention with a long record of use rather than a combination that has been measured. It belongs on the page as formulation context.
Marshmallow root is mucilaginous and coating, uva-ursi is astringent and drying, and traditional formulas combine them so the mucilage softens the astringency. Mucilage can also slow the absorption of co-taken actives, which cuts both ways. Read it as formulation practice.
Arbutin is a glucoside, and gut bacterial beta-glucosidases contribute to releasing its aglycone before hepatic conjugation. The composition of the gut community therefore shapes how much aglycone is generated from a given dose. That makes microbial status a variable in exposure rather than a synergy with a measured size.
Magnesium is a divalent cation and behaves like zinc, iron and calcium in front of a tannin-rich leaf preparation. The consequence is reduced solubility of the co-taken mineral, not a change in magnesium handling once absorbed. Separate the doses if both are wanted.
Nothing specific on file for Arctostaphylos Uva-Ursi Leaf. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Arctostaphylos Uva-Ursi Leaf actually does.
The defining constituent of the leaf is arbutin, a hydroquinone beta-D-glucoside, typically accompanied by smaller amounts of methylarbutin.
Arbutin is hydrolysed to its hydroquinone aglycone by gut and tissue beta-glucosidases, then largely reconjugated in the liver as hydroquinone glucuronide and sulphate before renal excretion.
Dried uva-ursi leaf is high in tannins, commonly described as fifteen to twenty percent, principally gallotannins, and these are what make the preparation astringent and what bind dietary and supplemental minerals in the gut.
The leaf also carries ursolic acid, gallic acid, and flavonol glycosides including quercetin and hyperoside, so a whole-leaf extract is a mixture and not an arbutin monopreparation.
Where Arctostaphylos Uva-Ursi Leaf comes from.
The leaves are picked, dried fast so the active compound survives, and either cut for tea or soaked in water or alcohol to make a concentrate. What ends up in the bottle depends on which liquid was used to pull it out.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A low evergreen shrub of northern heathland and boreal forest. Leaves are the harvested part, usually gathered by hand or by light mechanical stripping, with wild collection still common in parts of northern and eastern Europe alongside cultivated supply.
Leaves are dried at low temperature soon after harvest to stop enzymatic hydrolysis of arbutin by the plant's own glucosidases, then cut or milled. Slow or humid drying loses arbutin, which is why drying conditions matter more here than in many leaf materials.
For a concentrate the cut leaf is percolated or macerated with water or an ethanol and water mixture. Water favours arbutin and the polar tannins; adding ethanol brings across ursolic acid and less polar flavonoids as well. Neither is the same extract.
The liquid extract is concentrated under vacuum at reduced temperature and spray-dried or vacuum-dried, usually onto maltodextrin or a similar carrier.
The dried extract is assayed by HPLC and blended with carrier to hit a declared arbutin percentage. Pharmacopoeial monographs also set a botanical identity test and limits on foreign matter.
Material ships either as cut leaf for tea, as milled leaf in capsules, or as standardised extract powder pressed or encapsulated.
The forms it comes in.
The essence, in one line each.
- A single dose of a multi-ingredient thermogenic blend containing uva-ursi raised resting metabolic rate for a few hours in healthy adults, with only small changes in heart rate and blood pressure; the blend was tested as a whole, not uva-ursi alone.Randomised trial. Campbell et al., 2016 (Journal of the International Society of Sports Nutrition). PMID 27034624 ↗
These are the studies our verdict leans on, chosen from the 29 we read for Arctostaphylos Uva-Ursi Leaf. The full linked list is below.
Problems people have reported.
Read this carefully. These are 4,272 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Arctostaphylos Uva-Ursi Leaf is, not how risky it is. A report is not proof Arctostaphylos Uva-Ursi Leaf caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.